These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17127261)

  • 21. Recent advances in the development of tissue transglutaminase (TG2) inhibitors.
    Badarau E; Collighan RJ; Griffin M
    Amino Acids; 2013 Jan; 44(1):119-27. PubMed ID: 22160259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2.
    Ergülen E; Bécsi B; Csomós I; Fésüs L; Kanchan K
    Biochem J; 2016 Nov; 473(21):3889-3901. PubMed ID: 27551108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Dynamic Contrast Enhanced Magnetic Resonance Imaging to Evaluate Angiogenic Response and Vascular Permeability.
    Wallingford MC; Tarui T; Jayaraman N; Huggins GS; Dighe MK
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1507-1509. PubMed ID: 31339781
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring of transglutaminase 2 under different oxidative stress conditions.
    Caccamo D; Currò M; Ferlazzo N; Condello S; Ientile R
    Amino Acids; 2012 Feb; 42(2-3):1037-43. PubMed ID: 21805137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β
    Vyas FS; Nelson CP; Freeman F; Boocock DJ; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2017 Oct; 813():105-121. PubMed ID: 28754379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of protein modifications mediated by transglutaminase 2 in human viral diseases.
    Jeon JH; Kim IG
    Front Biosci; 2006 Jan; 11():221-31. PubMed ID: 16146727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transglutaminases: nature's biological glues.
    Griffin M; Casadio R; Bergamini CM
    Biochem J; 2002 Dec; 368(Pt 2):377-96. PubMed ID: 12366374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII.
    Souri M; Koseki-Kuno S; Takeda N; Yamakawa M; Takeishi Y; Degen JL; Ichinose A
    Thromb Haemost; 2008 Feb; 99(2):401-8. PubMed ID: 18278192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transglutaminases Are Active in Perivascular Adipose Tissue.
    Orr AN; Thompson JM; Lyttle JM; Watts SW
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33808023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structure and function of blood coagulation factor XIII (transglutaminase)].
    Takahashi N
    Tanpakushitsu Kakusan Koso; 1987 Jul; 32(8):1041-59. PubMed ID: 2890181
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.
    Rosenthal AK; Mosesson MW; Gohr CM; Masuda I; Heinkel D; Seibenlist KR
    Thromb Haemost; 2004 Mar; 91(3):558-68. PubMed ID: 14983233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
    Devine DV; Bishop PD
    Semin Thromb Hemost; 1996; 22(5):409-13. PubMed ID: 8989824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
    Király R; Thangaraju K; Nagy Z; Collighan R; Nemes Z; Griffin M; Fésüs L
    Amino Acids; 2016 Jan; 48(1):31-40. PubMed ID: 26250429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
    Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
    Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles and potential clinical implications of tissue transglutaminase in cardiovascular diseases.
    Chen S; Ma J; Chi J; Zhang B; Zheng X; Chen J; Liu J
    Pharmacol Res; 2022 Mar; 177():106085. PubMed ID: 35033646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII.
    Bakker EN; Pistea A; Spaan JA; Rolf T; de Vries CJ; van Rooijen N; Candi E; VanBavel E
    Circ Res; 2006 Jul; 99(1):86-92. PubMed ID: 16741156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Affinity Fluorogenic Substrate for Tissue Transglutaminase Reveals Enzymatic Hysteresis.
    Gates EWJ; Prince-Hallée A; Heidari Y; Sedighi A; Keillor JW
    Biochemistry; 2023 Nov; 62(21):3085-3095. PubMed ID: 37856791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative characterization of direct and indirect substrate probes for on-chip transamidating activity assay of transglutaminases.
    Lee K; Jung SH; Kong DH; Hwang BM; Han ET; Park SW; Park JH; Kim YM; Ha KS
    J Biotechnol; 2013 Dec; 168(4):324-30. PubMed ID: 24140601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.